1. Home
  2. ACXP vs PODC Comparison

ACXP vs PODC Comparison

Compare ACXP & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • PODC
  • Stock Information
  • Founded
  • ACXP 2017
  • PODC 2013
  • Country
  • ACXP United States
  • PODC United States
  • Employees
  • ACXP N/A
  • PODC N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • PODC
  • Sector
  • ACXP Health Care
  • PODC
  • Exchange
  • ACXP Nasdaq
  • PODC Nasdaq
  • Market Cap
  • ACXP 8.4M
  • PODC 44.1M
  • IPO Year
  • ACXP 2021
  • PODC N/A
  • Fundamental
  • Price
  • ACXP $0.47
  • PODC $2.18
  • Analyst Decision
  • ACXP Strong Buy
  • PODC
  • Analyst Count
  • ACXP 2
  • PODC 0
  • Target Price
  • ACXP $10.00
  • PODC N/A
  • AVG Volume (30 Days)
  • ACXP 18.7M
  • PODC 121.6K
  • Earning Date
  • ACXP 08-08-2025
  • PODC 08-12-2025
  • Dividend Yield
  • ACXP N/A
  • PODC N/A
  • EPS Growth
  • ACXP N/A
  • PODC N/A
  • EPS
  • ACXP N/A
  • PODC N/A
  • Revenue
  • ACXP N/A
  • PODC $52,119,000.00
  • Revenue This Year
  • ACXP N/A
  • PODC $19.39
  • Revenue Next Year
  • ACXP N/A
  • PODC $23.41
  • P/E Ratio
  • ACXP N/A
  • PODC N/A
  • Revenue Growth
  • ACXP N/A
  • PODC 20.36
  • 52 Week Low
  • ACXP $0.30
  • PODC $1.10
  • 52 Week High
  • ACXP $3.33
  • PODC $2.94
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 52.38
  • PODC 49.55
  • Support Level
  • ACXP $0.45
  • PODC $2.01
  • Resistance Level
  • ACXP $0.59
  • PODC $2.94
  • Average True Range (ATR)
  • ACXP 0.08
  • PODC 0.35
  • MACD
  • ACXP -0.01
  • PODC -0.03
  • Stochastic Oscillator
  • ACXP 27.06
  • PODC 31.47

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About PODC PodcastOne Inc.

PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.

Share on Social Networks: